Alkermes Plc
NASDAQ:ALKS
Alkermes Plc
Operating Income
Alkermes Plc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Alkermes Plc
NASDAQ:ALKS
|
Operating Income
$420.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
28%
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Operating Income
-$17.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
31%
|
CAGR 10-Years
21%
|
|
Prothena Corporation PLC
NASDAQ:PRTA
|
Operating Income
-$191m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-17%
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Operating Income
-$196.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Alkermes Plc's Operating Income?
Operating Income
420.1m
USD
Based on the financial report for Dec 31, 2023, Alkermes Plc's Operating Income amounts to 420.1m USD.
What is Alkermes Plc's Operating Income growth rate?
Operating Income CAGR 10Y
28%